Evidence map›Paper›PMID 32095882›Full record

ReviewWorld journal of urology2020

Infectious complications of prostate biopsy: winning battles but not war.

Okan Derin, Limírio Fonseca, Rafael Sanchez-Salas, Matthew J Roberts

Registry-linked trialAbstract readReview
PubMed Publisher
In one paragraph

Review in World journal of urology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06359964 (Infective Complications in Transperineal Prostate Biopsy Without Antibiotic Prophylaxis), which is not on this map. Cited by 30 papers.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed
3.5field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06359964 nacompletednot on this mapstarted 2024, after this paper: background citation

Infective Complications in Transperineal Prostate Biopsy Without Antibiotic Prophylaxis: A Prospective Cohort Study

TypeinterventionalSponsorChinese University of Hong KongRan2024 to 2025Enrolled1,753ConditionsProstate CancerArmsTransperineal Biopsy without antibiotics prophylaxis, Transperineal Biopsy with antibiotics prophylaxis
3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 49 citations in OpenAlex.

  1. Review
  2. Review
  3. [Efficiency and safety of transperineal prostate biopsy with a single access point].Revista medica del Instituto Mexicano del Seguro Social · 2026
    Observational
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Review
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 4 institutions in 4 countries.

Okan DerinInternational School of Medicine, Medipol Mega Hospital, Istanbul Medipol University, Bagcilar, 34214, Istanbul, Turkey. oderin@medipol.edu.tr.ORCID http://orcid.org/0000-0001-6311-5428
Limírio FonsecaHospital das Clinicas da Universidade de São Paulo, São Paulo, Brazil.
Rafael Sanchez-SalasDepartment of Urology, L'Institut Mutualiste Montsouris, Paris, France.
Matthew J RobertsDepartment of Urology, Royal Brisbane and Women's Hospital, Brisbane, Australia.ORCID http://orcid.org/0000-0003-0552-7402
Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo · BRInstitute Mutualiste Montsouris · FRIstanbul Medipol University · TRThe University of Queensland · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundProstate biopsy is a standard tool for diagnosing prostate cancer, with more than 4 million procedures performed worldwide each year. Infectious complications and economic burden are reportedly rising with continued use of trans-rectal ultrasound-guided biopsy, despite the transperineal approach being associated with less infectious complications. OBJECTIVE AND

methodsIn this review, the contemporary literature on pathophysiology, epidemiology, risk factors, causative organisms and emerging approaches for prevention of infectious complications are outlined.

resultsManagement of infectious complications after TRUSB has caused significant financial burden on health systems. The most frequent causative agents of infectious complications after prostate biopsy are Gram-negative bacilli are particularly concerning in the era of antibiotic resistance. Increasing resistance to fluoroquinolones and beta-lactam antibiotics has complicated traditional preventive measures. Patient- and procedure-related risk factors, reported by individual studies, can contribute to infectious complications after prostate biopsy.

conclusionsRecent literature shows that the transrectal ultrasound-guided prostate biopsy results in higher infectious complication rate than the transperineal prostate biopsy. NAATs, recently introduced technique to detect FQr may detect all antibiotic-resistant rectal microbiota members-included MDRs-although the technique still has limitations and economical burdens. Transient solutions are escalating antibiotic prophylaxis and widening the indications for TPB.

Indexed as

AlgorithmsBacterial InfectionsBiopsyHumansMalePostoperative ComplicationsProstateProstatic NeoplasmsAntimicrobial resistanceInfectious complicationsPreventive measuresProstate biopsy

Identifiers

PMID32095882
OpenAlexW3007912668

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.